NCT05638828

A Study of RD14-01 in Patients With Advanced Solid Tumors

Study Summary

This study will evaluate the safety and tolerability of RD14-01, a ROR1-targeted CAR T-cell therapy, in patients with ROR1+ advanced solid tumors.

Want to learn more about this trial?

Request More Info

RD14-01 Cell injectionDRUG

RD14-01 Cell injection

No locations listed.

Data sourced from ClinicalTrials.gov. Last updated: April 14, 2026